ImmunityBio, Inc. (IBRX)
NASDAQ·Healthcare·Biotechnology
$6.82
-2.22%
Mkt Cap $7.32B
Analyst Ratings
Buy
15
Hold
0
Sell
0
Price Target (6 analysts)
$13.00
Range $12.00 – $15.00
Implied Upside
+90.8%
Consensus $13.00 vs current $6.82
NASDAQ·Healthcare·Biotechnology
$6.82
-2.22%
Mkt Cap $7.32B
Buy
15
Hold
0
Sell
0
Price Target (6 analysts)
$13.00
Range $12.00 – $15.00
+90.8%
Consensus $13.00 vs current $6.82